In 2015, the FDA decided that “picamilon is a substance that does not meet the statutory definition of a dietary ingredient.” The existing investigation did not require both animal or human subjects; therefore, protocol acceptance, scientific trial registration and client consents were not applicable. Past study discovered similar discrep